Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[How to interprete hypercalcitoninemia?].

N Levy-Bohbot1, M Patey, H Larbre

  • 1Service d'endocrinologie-diabétologie-maladies métaboliques, CHRU de Reims, hôpital Robert-Debré, avenue du Général-Koenig, 51092 Reims cedex, France. nathalie.levybohbot@ch-epernay.fr

La Revue De Medecine Interne
|July 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and glycemic outcomes of DBLG1 coupled to the DANA-i pump in adults and adolescents with type 1 diabetes mellitus. The SP8 trial.

Journal of endocrinological investigation·2025
Same author

Practical implementation of automated insulin delivery systems in 2025: A French position statement update.

Diabetes & metabolism·2025
Same author

Cartilage repair strategies in the knee according to Dutch Orthopedic Surgeons: a survey study.

Archives of orthopaedic and trauma surgery·2023
Same author

To what extent do social support and mastery mediate the association between childhood maltreatment and depression? A sequential causal mediation analysis.

Epidemiology and psychiatric sciences·2022
Same author

Unilateral or bilateral adrenalectomy in PPNAD: six cases from a single family followed up over 40 years.

Endocrine·2022
Same author

Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).

Orphanet journal of rare diseases·2022
Same journal

[Atypical low back pain].

La Revue de medecine interne·2026
Same journal

[Polycythemia associated chronic haemolysis].

La Revue de medecine interne·2026
Same journal

[Persistent headaches in a 55 year-old man].

La Revue de medecine interne·2026
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
See all related articles

Calcitonin assays aid in diagnosing thyroid medullary cancer. Understanding benign hypercalcitoninemia is crucial for appropriate patient management and avoiding unnecessary invasive treatments.

Area of Science:

  • Endocrinology
  • Oncology
  • Diagnostic Medicine

Background:

  • Calcitonin is a key marker for thyroid medullary cancer.
  • Hypercalcitoninemia can stem from non-cancerous conditions like renal failure or C-cell hyperplasia.
  • Interpreting calcitonin levels requires careful consideration of various factors.

Purpose of the Study:

  • To review the role of calcitonin assays in diagnosing thyroid medullary cancer.
  • To discuss the differential diagnosis of hypercalcitoninemia beyond thyroid medullary cancer.
  • To highlight recent advancements in interpreting calcitonin levels for nodular thyroid disease management.

Main Methods:

  • Review of physiological role of calcitonin and assay methodologies.
  • Analysis of recent studies on calcitonin specificity and sensitivity in nodular thyroid disease.

Related Experiment Videos

  • Discussion of clinical guidelines for managing hypercalcitoninemia.

    • Main Results:

    • Established calcitonin thresholds aid in decision-making for nodular thyroid disease.
    • Recent large-scale studies improve understanding of calcitonin test performance.
    • Distinguishing malignant from benign causes of hypercalcitoninemia is increasingly feasible.

    Conclusions:

    • Calcitonin testing is becoming more frequent for thyroid nodule diagnosis.
    • Accurate interpretation of calcitonin levels is essential for optimal patient care.
    • Appropriate use of calcitonin assays helps reserve aggressive treatments for indicated cases.